/24-7PressRelease/ - MONROVIA, CA, January 26, 2008 - Dr. Christophe Labie, Group Leader of the Molecular Neurobiology Group at Sanofi-Aventis will give a presentation entitled "Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain" at GTCbio's 4th Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA.
Regeneration-based therapy is an emerging area in modern medicine, as is evidenced by numerous publications over the last decade. Published studies provide strong evidence that neural stem cells or progenitor cells (herein referred to as NSCs) persist and are widely distributed throughout the adult nervous system. In the injured or diseased CNS, NSCs self replicate, migrate to damaged areas, and attempt to repair damage by differentiating into neurons, astrocytes, and/or mature myelin forming oligodendrocytes. One focus of the Sanofi-Aventis CNS department is to identify pharmacological compounds that favor brain repair by enhancing physiological natural repair processes. More specifically, the increase of neuronal replacement by compounds stimulating endogenous neurogenesis, such as xaliproden, will be presented.
Besides Dr. Labie's presentation, the conference also features presentations from other leading organizations such as Beckman Research Institute, FDA, Genzyme, Merck, MIT, Pfizer, Sangamo BioSciences, Sanofi Aventis, University of Van Amsterdam, Whitehouse Institute, and many more. The full agenda is available online at http://www.gtcbio.com.
GTCbio's 4th Stem Cell Research & Therapeutics will cover topics as Stem Cell Biology, Adult Stem Cells, Embryonic Stem Cells, Differentiation of Stem Cells, Epigenomics & Reprogramming of Stem Cells, Regenerative Medicine & Therapeutics, Stem Cell Imaging, Regulatory Aspects & Funding Opportunities, Cancer Stem Cells, and Stem Cell Applications in Drug Discovery.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/userAgenda.aspx?id=120
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
- adult, asc, brain, cancer, cell, cells, differentiated, differentiating, differentiation, embryonic, epigenomics, esc, neurogenesis, retention, stem, therapies, therapy
Read more Press Releases from Rania Hafez:- Allergan and CMO at Altheos to speak at Ocular Drug Discovery conference Feb 27-28, 2012 Las Vegas
- AstraZeneca, GSK to speak at Anti-infectives Partnering meeting Nov 7-8, Boston
- Glenn D. Prestwich to speak at 7th Modern Drug Discovery Summit Oct 19-21 2011 in San Diego, CA
- Vice President at Johnson and Johnson to speak at Modern Drug Summit Oct 19-21 2011 in San Diego, CA
- Biosimilars and FDA talk at 4th Protein Discovery & Therapeutics Conference Oct 19-21 in San Diego
- Dr. Joseph Joyce, Director At Merck & Co., To Speak At Vaccines Meeting On Nov. 7-8 In Boston, MA.
- Klarquist Sparkman to speak at 4th Protein Discovery & Therapeutics Meeting Oct 19-21 in San Diego
- Dr. Philip Dormitzer, Head at Novartis, to Speak at Vaccines Meeting on Nov. 7-8 in Boston, MA
- Klaus Mendla, Global Head at Boehringer to speak at CNS Partnering meeting Sept 22-23, San Francisco
- Dr. Kanta Subbarao, Chief at the NIH, to speak at vaccines meeting on Nov. 7-8 in Boston, MA
Other Press Release Headlines:
